National and Regional Medicare Spending on Tafamidis, 2019-2021
This cross-sectional study describes national and regional Medicare spending and out-of-pocket costs for tafamidis from its approval in 2019 to 2021.
Authors
- Philip J. Blatt (ORCID: https://orcid.org/0000-0001-9785-4413)
- Ahmad Masri (ORCID: https://orcid.org/0000-0002-6390-6526)
- Timothy F. Simpson (ORCID: https://orcid.org/0000-0002-8580-0773)
- Hongya Chen (ORCID: https://orcid.org/0000-0002-8648-9251)
Institutions
- Oregon Health & Science University (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.26086
- Citations
- 9
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.10